Check out this week's QuadCast as we summarize the most important results from ASCO 2023. This includes the PROSPECT trial for rectal cancer, final reporting of the ADAURA trial for NSCLC, a targeted therapeutic for IDH mutated gliomas, and much more. Quadshotnews@gmail.com
Check out this week's QuadCast as we summarize the most important results from ASCO 2023. This includes the PROSPECT trial for rectal cancer, final reporting of the ADAURA trial for NSCLC, a targeted therapeutic for IDH mutated gliomas, and much more.
Quadshotnews@gmail.com